Lineage Cell Therapeutics (LCTX) Capital Leases (2015 - 2026)
Lineage Cell Therapeutics (LCTX) posted quarterly Capital Leases of $22000.0 for Q1 2026, down 56.86% year-over-year from $51000.0 in Q1 2025, and down 31.25% quarter-over-quarter from $32000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Capital Leases (2015 - 2026) Analysis & Trends
Lineage Cell Therapeutics' Capital Leases history runs 12 years deep, the most recent figure standing at $22000.0 for Q1 2026.
- In Q1 2026, Capital Leases fell 56.86% year-over-year to $22000.0; the TTM figure through Mar 2026 stood at $22000.0 (down 56.86% YoY), while the FY2025 annual figure was $32000.0, down 52.24% from the prior year.
- Capital Leases for Q1 2026 stood at $22000.0, down from $32000.0 in the prior quarter.
- The five-year high for Capital Leases was $133000.0 in Q1 2023, with the low at $16000.0 in Q3 2022.
- The 5-year median for Capital Leases is $67000.0 (2024), against an average of $62705.9.
- The sharpest annual moves came in 2023 and 2026: Capital Leases soared 506.25% in 2023, then slumped 56.86% in 2026.
- Lineage Cell Therapeutics' Capital Leases stood at $84000.0 in 2022, then climbed by 8.33% to $91000.0 in 2023, then retreated by 26.37% to $67000.0 in 2024, then tumbled by 52.24% to $32000.0 in 2025, then plunged by 31.25% to $22000.0 in 2026.
- Business Quant data shows LCTX's Capital Leases at $22000.0 in Q1 2026, $32000.0 in Q4 2025, and $40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 12,000.00 |